The Value of Pharmaceutical Innovation: Concepts and Assessment: The Critical Path to Innovation

Mir-Saeed Shayegan Salek; P. Kamudoni

doi:10.1002/9783527693405

The Value of Pharmaceutical Innovation: Concepts and Assessment: The Critical Path to Innovation

Mir-Saeed Shayegan Salek, P. Kamudoni

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The reality of low productivity of current pharmaceutical research in terms of new molecules and rising cost of development begs a fresh approach to creativity. This is coupled with major trust issues as a perceived lack of transparency which has eroded confidence in both pharmaceutical companies and the public institutions that regulate them.

Original language	English
Title of host publication	Value Creation in the Pharmaceutical Industry
Editors	Alexander Schuhmacher, Markus Hinder, Oliver Gassmann
Place of Publication	Weinheim
Publisher	Wiley-VCH Verlag
Chapter	3
Pages	44-59
Number of pages	16
ISBN (Electronic)	9783527693405
ISBN (Print)	9783527339136
DOIs	https://doi.org/10.1002/9783527693405
Publication status	Published - 15 Jan 2016

Access to Document

10.1002/9783527693405Licence: Other

Cite this

@inbook{a3c472b32e064c98bf8e89b5a0ec06d8,

title = "The Value of Pharmaceutical Innovation: Concepts and Assessment: The Critical Path to Innovation",

abstract = "The reality of low productivity of current pharmaceutical research in terms of new molecules and rising cost of development begs a fresh approach to creativity. This is coupled with major trust issues as a perceived lack of transparency which has eroded confidence in both pharmaceutical companies and the public institutions that regulate them.",

author = "Salek, {Mir-Saeed Shayegan} and P. Kamudoni",

year = "2016",

month = jan,

day = "15",

doi = "10.1002/9783527693405",

language = "English",

isbn = "9783527339136",

pages = "44--59",

editor = "Alexander Schuhmacher and Markus Hinder and Oliver Gassmann",

booktitle = "Value Creation in the Pharmaceutical Industry",

publisher = "Wiley-VCH Verlag",

address = "Germany",

}

TY - CHAP

T1 - The Value of Pharmaceutical Innovation: Concepts and Assessment: The Critical Path to Innovation

AU - Salek, Mir-Saeed Shayegan

AU - Kamudoni, P.

PY - 2016/1/15

Y1 - 2016/1/15

N2 - The reality of low productivity of current pharmaceutical research in terms of new molecules and rising cost of development begs a fresh approach to creativity. This is coupled with major trust issues as a perceived lack of transparency which has eroded confidence in both pharmaceutical companies and the public institutions that regulate them.

AB - The reality of low productivity of current pharmaceutical research in terms of new molecules and rising cost of development begs a fresh approach to creativity. This is coupled with major trust issues as a perceived lack of transparency which has eroded confidence in both pharmaceutical companies and the public institutions that regulate them.

U2 - 10.1002/9783527693405

DO - 10.1002/9783527693405

M3 - Chapter

SN - 9783527339136

SP - 44

EP - 59

BT - Value Creation in the Pharmaceutical Industry

A2 - Schuhmacher, Alexander

A2 - Hinder, Markus

A2 - Gassmann, Oliver

PB - Wiley-VCH Verlag

CY - Weinheim

ER -

The Value of Pharmaceutical Innovation: Concepts and Assessment: The Critical Path to Innovation

Abstract

Access to Document

Fingerprint

Cite this